Trial Profile
Pilot bioequivalence study for ELI-201 [Oxycodone/naltrexone]
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2013
Price :
$35
*
At a glance
- Drugs Oxycodone/naltrexone (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Elite Pharmaceuticals
- 07 Dec 2013 New trial record
- 06 Dec 2013 The first subject has been dosed, according to a media release.